EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Gut Microbiota and Metabolic Modulation by Slow-Release Protein Substitutes in Phenylketonuria: Findings from the PREMP Study

Martina Tosi iD, Matteo Domenico Marsiglia iD, Emerenziana Ottaviano iD, Sara Parolisi iD, Juri Zuvadelli iD, Silvia Ancona iD, Camilla Ceccarani iD, Maria Teresa Carbone iD, Graziella Cefalo iD, Elisa Borghi iD, Elvira Verduci iD

Nutrients · 07.12.2025 · 17 (24) · 3829

DOI: 10.3390/nu17243829 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Nutrients, online erschienen am 07.12.2025. Verfasst von Martina Tosi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences, University of Milan, 20142 Milan, Italy. Hauptthemen laut MEDLINE: Phenylketonurias, Gastrointestinal Microbiome, Dietary Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Health Sciences, University of Milan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Phenylketonuria (PKU) is an inherited metabolic disorder requiring early and lifelong dietary management through a low-phenylalanine (Phe) diet supplemented with Phe-free protein substitutes (PS). Recently developed slow-release PS formulations aim to mimic natural protein absorption, enhancing metabolic stability and tolerability. The PREMP study (effect of Protein RElease on the Microbiota composition and function in Phenylketonuric subjects) assessed the effects of a slow-release, Phe-free PS on gut microbiota composition and metabolic parameters in patients with PKU.

Methods

Patients aged ≥6 years with PKU were enrolled from two Italian centers (Milan and Naples). Participants replaced ≥50% of their usual protein equivalent (P.Eq.) intake from Phe-free PS with a slow-release PS for 4 months. Clinical, biochemical, and nutritional assessments were performed at baseline and post-intervention. Gut microbiota composition was analyzed by 16S rRNA gene sequencing, and fecal fatty acids were quantified by gas chromatography–mass spectrometry.

Results

Thirteen patients (median age 17 years) completed the intervention, replacing on average 78% of their usual P.Eq. intake with the slow-release formulation. Plasma phenylalanine and tyrosine levels remained stable, while fasting insulin (p = 0.0185) and HOMA-IR (p = 0.0099) significantly decreased, indicating improved insulin sensitivity. Anthropometric and dietary parameters showed no significant changes. Gut microbiota diversity remained stable, with modest increases in microbial richness and beneficial genera such as Bacteroides, Bifidobacterium, and Gemmiger, while Hafnia, Anaerostipes and Romboutsia decreased. Fecal butyrate and other fatty acids showed slight, non-significant increases.

Conclusions

The slow-release PS was safe, well-tolerated, and improved insulin sensitivity without affecting amino acid or nutritional status. Microbial changes suggest potential benefits for gut health, warranting confirmation in larger, long-term studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhenylketonuriasGastrointestinal MicrobiomeDietary ProteinsHumansMaleFemaleAdolescentPhenylalanineYoung AdultDelayed-Action PreparationsChildAdultFecesInsulinItalyTyrosine

Stichwörter der Autor:innen

Phenylketonuriaglucosegut-microbiotainsulinprotein substitutesshort chain fatty acidsslow-release amino acids

Substanzen

PhenylalanineDelayed-Action PreparationsDietary ProteinsInsulinTyrosine

Autor:innen und Institutionen

  • Department of Health Sciences, University of Milan, 20142 Milan, Italy.
  • Department of Pediatrics, Vittore Buzzi Children's Hospital, 20154 Milan, Italy.
  • UOSD Metabolic Diseases, AORN Santobono-Pausilipon, 80122 Naples, Italy.
  • Clinical Department of Pediatrics, San Paolo Hospital, ASST Santi Paolo e Carlo, 20142 Milan, Italy.
  • Institute of Biomedical Technologies, National Research Council, 20054 Segrate, Italy.

ORCID-Profile: Martina Tosi, Matteo Domenico Marsiglia, Emerenziana Ottaviano, Sara Parolisi, Juri Zuvadelli, Silvia Ancona, Camilla Ceccarani, Maria Teresa Carbone, Graziella Cefalo, Elisa Borghi, Elvira Verduci

Förderung

  • Department of Health Sciences, University of Milan

Zitieren

APA

Tosi, M., Marsiglia, M. D., Ottaviano, E., Parolisi, S., Zuvadelli, J., Ancona, S., Ceccarani, C., Carbone, M. T., Cefalo, G., Borghi, E., & Verduci, E. (2025). Gut Microbiota and Metabolic Modulation by Slow-Release Protein Substitutes in Phenylketonuria: Findings from the PREMP Study. Nutrients, 17(24), 3829. https://doi.org/10.3390/nu17243829

Vancouver

Tosi M, Marsiglia MD, Ottaviano E, Parolisi S, Zuvadelli J, Ancona S, et al. Gut Microbiota and Metabolic Modulation by Slow-Release Protein Substitutes in Phenylketonuria: Findings from the PREMP Study. Nutrients. 2025;17(24):3829. doi:10.3390/nu17243829

BibTeX
@article{Tosi2025,
  author = {Tosi, Martina and Marsiglia, Matteo Domenico and Ottaviano, Emerenziana and Parolisi, Sara and Zuvadelli, Juri and Ancona, Silvia and Ceccarani, Camilla and Carbone, Maria Teresa and Cefalo, Graziella and Borghi, Elisa and Verduci, Elvira},
  title = {Gut Microbiota and Metabolic Modulation by Slow-Release Protein Substitutes in Phenylketonuria: Findings from the PREMP Study},
  journal = {Nutrients},
  year = {2025},
  volume = {17},
  number = {24},
  pages = {3829},
  doi = {10.3390/nu17243829}
}
Kostenlos starten →